Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Human Longevity has raised $39.8M in total funding. The most recent round was Series B. The last funding was announced in August 2024.
Human Longevity's investors include Amino Capital, Illumina Ventures, Illumina, TVM Capital Healthcare, Viridos.
Human Longevity is headquartered in San Diego, United States.
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Human Longevity is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Human Longevity — Funding & Investors." VCBacked, August 21, 2024, https://www.vcbacked.co/company/human-longevity. Accessed August 13, 2026.
VCBacked. (2024). Human Longevity — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/human-longevity
{{cite web |title=Human Longevity — Funding & Investors |url=https://www.vcbacked.co/company/human-longevity |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated